Nls Pharmaceutics Ltd (NQ: NLSP )
0.1752
-0.0026
(-1.46%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Nls Pharmaceutics Ltd
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
February 23, 2024
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Notice of Deficiency with Nasdaq Continued Listing Requirements
January 12, 2024
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics CEO Issues Letter to Shareholders
December 29, 2023
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/image41.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/03/spot_spotify_1600.png)
![](https://investorplace.com/wp-content/uploads/2023/04/fsr1600.png)
![](https://investorplace.com/wp-content/uploads/2019/07/ipo-chart-businessman.jpg)
![](https://investorplace.com/wp-content/uploads/2019/10/medicine.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/04/hawaiian_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics Announces Election of Additional Board Members
November 28, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/11/16/childrens_place_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/16/annoy-2926087.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/11/13/image41_0.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NLS Pharmaceutics Announces Company Update on Strategic Partnerships
October 12, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/10/02/image39.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023
September 14, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/31/image31.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.